Skip to main content



Legend
Presentation Icons
Assessor Sessions
Assessor Sessions
Committee Meetings
Committee Meetings
Foundation
Foundation
Networking Events
Networking Events
Oral Abstracts
Oral Abstracts

Full Schedule

Full Schedule

  • Monday, October 27, 2025
  • 6:30 AM - 6:30 PM  PT
    REGISTRATION
  • 7:00 AM - 8:30 AM  PT
    Awards Committee Meeting
  • 7:00 AM - 6:00 PM  PT
    Speaker Ready Room
  • 7:30 AM - 5:30 PM  PT
    Bookstore and AABB Central
  • 7:30 AM - 6:00 PM  PT
    Coat and Luggage Check
  • 8:15 AM - 9:15 AM  PT
    CBC: Lightning Talks- The Future of Cord Blood: Bold Visions & Innovations
  • 8:15 AM - 9:15 AM  PT
    Iron Matters: Regulating the Metal That Makes Blood Red (Landsteiner-Alter Award and Lectureship)
  • 9:30 AM - 4:30 PM  PT
    Exhibit Hall Open
  • 10:00 AM - 11:30 AM  PT
    AABB/ASHI Symposium: Exploring Transplant Uncertainties/Conundrums in ABO
  • 10:00 AM - 11:30 AM  PT
    AABB’s Updated Platelet and Red Blood Cell Transfusion Guidelines
  • 10:00 AM - 11:30 AM  PT
    Blood Conservation in the OR: How to Create a Comprehensive Pediatric Patient Blood Management Program
  • 10:00 AM - 11:30 AM  PT
    CBC: A New Era for Cord Blood - The National Cord Blood Network
  • 10:00 AM - 11:30 AM  PT
    Cell Therapy Lab Jeopardy!
  • 10:00 AM - 11:30 AM  PT
    Closing the Divide: Pathways to Engaging Underrepresented Communities in Blood Donation
  • 10:00 AM - 11:30 AM  PT
    Expanding Access, Ensuring Safety: Best Practices in Out-of-Hospital Transfusion
  • 10:00 AM - 11:30 AM  PT
    Lord of the Antibodies
  • 10:00 AM - 11:30 AM  PT
    AM25-MN-04-L - AABB Transfusion Medicine Subsection Committee Survey on Directed Blood Donation Practices
  • 10:00 AM - 11:30 AM  PT
    AM25-MN-04-L - Assessment of Donor Presentation Times Relative to HIV Acquisition During Different Deferral Policies in the U.S. Based on Quantitative Biomarker Testing
  • 10:00 AM - 11:30 AM  PT
    AM25-MN-04-L - Demographics and Characteristics of First-Time Blood Donors: Comparison of the Implementation of 3-Month Deferral vs Individual Donor Assessment Policies for High-Risk Behaviors
  • 10:00 AM - 11:30 AM  PT
    AM25-MN-04-L - Oral Abstract Spotlight Session - Cutting Edge Insights into Blood Donations and Allocations
  • 10:00 AM - 11:30 AM  PT
    AM25-MN-04-L - Surge and Sustain: Crisis-Driven Donation Patterns in Whole Blood vs. Apheresis Platelets
  • 10:00 AM - 11:30 AM  PT
    AM25-MN-18-L - Analysis of Impact to HLA Coverage and Usability of Cord Blood Units Banked Between 2017 and 2024
  • 10:00 AM - 11:30 AM  PT
    AM25-MN-18-L - Ex Vivo and In Vivo Potency of CD34+ Hematopoietic Stem and Progenitor Cells Isolated from Cord Blood Using a Novel Technology
  • 10:00 AM - 11:30 AM  PT
    AM25-MN-18-L - Oral Abstract Session - Advances in Cord Blood Therapy
  • 10:00 AM - 11:30 AM  PT
    AM25-MN-18-L - Umbilical Cord Blood Transplantation (UCBT) a Very Good Curative Option for Pediatric Patients with Congenital Disorders Even in the Setting of Underrepresented Minorities
  • 11:30 AM - 1:00 PM  PT
    Attendee Lunch
  • 11:30 AM - 1:00 PM  PT
    Physicians Leadership Roundtable
  • 12:00 PM - 1:00 PM  PT
    Annual Meeting Education Committee Meeting
  • 12:05 PM - 1:30 PM  PT
    Transfusion Medicine Coordinating Committee and John Elliott Memorial Award Meeting
  • 12:05 PM - 1:45 PM  PT
    Quality and Regulatory Subsection Meeting
  • 12:05 PM - 1:55 PM  PT
    Global Transfusion Forum Meeting
  • 12:30 PM - 1:30 PM  PT
    AABB Transfusion Transmitted Diseases Committee Meeting
  • 2:30 PM - 3:30 PM  PT
    “I Want It That Way” - Ethical Dilemmas in Pediatric Transfusion Medicine
  • 2:30 PM - 3:30 PM  PT
    Advances in Labeling: Practical Applications of 2-D Data Matrix Symbols with ISBT 128
  • 2:30 PM - 3:30 PM  PT
    Advancing Cord Blood Utilization: Building Pathways for Innovation and Clinical Adoption
  • 2:30 PM - 3:30 PM  PT
    From Blueprint to Benchmark: A Journey Through AABB Standards Development and Accreditation
  • 2:30 PM - 3:30 PM  PT
    From Fellow to Faculty: Practical Insights for Trainees and Early Career Physicians
  • 2:30 PM - 3:30 PM  PT
    Uncovering New Blood Groups: Impacts in Transfusion and Beyond (Sally Frank Award and Lectureship)
  • 2:30 PM - 3:30 PM  PT
    AM25-MN-19-L - Blood Resource Allocation in Oklahoma: A Geospatial Analysis on Available Blood Supply and Potential Networks of Distribution
  • 2:30 PM - 3:30 PM  PT
    AM25-MN-19-L - Evaluating Immersive Virtual Reality as a Training Tool for Crossmatching in Transfusion Laboratories
  • 2:30 PM - 3:30 PM  PT
    AM25-MN-19-L - Oral Abstract Session - Application of Novel Technology in Transfusion Medicine
  • 2:30 PM - 3:30 PM  PT
    AM25-MN-19-L - Prospective Validation of an Artificial Intelligence Clinical Decision Support System for Preoperative Blood Orders
  • 2:30 PM - 3:30 PM  PT
    AM25-MN-19-L - TransfusaScope: Visualizing the Physiologic Response — Before, During, and After Transfusion
  • 3:45 PM - 4:45 PM  PT
    Ask the Standards
  • 3:45 PM - 4:45 PM  PT
    Blood Bank IT: Compliance and Data Management Concepts
  • 3:45 PM - 4:45 PM  PT
    Plasma Failure in Multiple Organ Dysfunction Syndrome (MODS)
  • 3:45 PM - 4:45 PM  PT
    The Top Nonconformances Stratified by Facility Size and Location. Where Do You Fit?
  • 3:45 PM - 4:45 PM  PT
    Transfusing Safely and Wisely: Much Progress But Still Need to Do Better (Emily Cooley Memorial Award and Lectureship)
  • 3:45 PM - 4:45 PM  PT
    Transfusion Medicine Education for Physicians: Ready-to-Use, Customizable, and Innovative Teaching Tools
  • 3:45 PM - 4:45 PM  PT
    AM25-MN-20-L - Novel JK*A(160T) Identified in a Pediatric Patient with Anti-Jka: Evidence from Family-Based Investigation
  • 3:45 PM - 4:45 PM  PT
    AM25-MN-20-L - Oral Abstract Session - New Variants in Kid & ABO
  • 3:45 PM - 4:45 PM  PT
    AM25-MN-20-L - Variants Causing Altered Expression of ABO Antigens
  • 3:45 PM - 4:45 PM  PT
    AM25-MN-21-L - Hemostatic Efficacy of Prothrombin Complex Concentrate for Managing Coagulopathic Bleeding in Surgical Patients: Results from the LEX-209 and LEX-211 (FARES-II) Phase 3 Trials
  • 3:45 PM - 4:45 PM  PT
    AM25-MN-21-L - Impact and Frequency of Intravenous Fluid Contamination of Complete Blood Counts: A Multicenter Retrospective Study: 'Times New Roman',serif; Mso-fareast-font-family: 'Times New Roman'; Color: Black; Mso-themecolor: text1; Mso-font-kerning: 0pt; Mso-ligatures: None;">
  • 3:45 PM - 4:45 PM  PT
    AM25-MN-21-L - Oral Abstract Session - Hematology & Coagulation
  • 3:45 PM - 4:45 PM  PT
    AM25-MN-21-L - Rapidly Fatal Adult Case of Ceftriaxone-Induced Immune Hemolytic Anemia
  • 3:45 PM - 4:45 PM  PT
    AM25-MN-21-L - Use of Sutimlimab to Treat a Complement Binding Auto-anti-AnWj Antibody in a Patient with Refractory B-Cell Lymphoma
  • 3:45 PM - 6:00 PM  PT
    CBC: State of the Science Symposium – Striking a New Cord in the Evolution of Stem Cell Transplant (sponsored by Gamida Cell)
  • 5:00 PM - 6:00 PM  PT
    A Tale of Twice-Annual Verification: Why Two Matter, and Who’s Looking?
  • 5:00 PM - 6:00 PM  PT
    CABP Prep
  • 5:00 PM - 6:00 PM  PT
    Computer Systems Under Attack: Cybersecurity Best Practices and Lessons Learned
  • 5:00 PM - 6:00 PM  PT
    Crossmatch Incompatible Transfusions: How Collaboration Between Transfusion Services and Immunohematology Reference Laboratories Enhance Patient Safety
  • 5:00 PM - 6:00 PM  PT
    Debate: Therapeutic Leukapheresis in Hyperleukocytosis—Data-Driven or Dubious?
  • 5:00 PM - 6:00 PM  PT
    Safety, Standards, and Sanity: Navigating Compliance in Emergent Blood Product Release
  • 5:00 PM - 6:00 PM  PT
    Unlocking the Power of Extracellular Vesicles: From Intercellular Communication to Therapeutic Innovation
  • 5:00 PM - 6:00 PM  PT
    AM25-MN-35-L - A Randomized, Controlled Pilot Clinical Trial of Extended-stored Cold-stored Platelets in 100% Plasma for Cardiothoracic Surgical Bleeding: The CHASE Trial
  • 5:00 PM - 6:00 PM  PT
    AM25-MN-35-L - Donor Genetics and Storage Conditions Influence Mitochondrial DNA Levels in RBC Units
  • 5:00 PM - 6:00 PM  PT
    AM25-MN-35-L - Oral Abstract Session - New Insights into Components, Storage, and Patient Outcomes
  • 5:00 PM - 6:00 PM  PT
    AM25-MN-35-L - Oxygen-Restricted, Cold Storage Preserves Platelet Function and Count Amid Divergent Oxidative Stress Responses
  • 5:00 PM - 6:00 PM  PT
    AM25-MN-35-L - The Impact of Donor Sex on Platelet Hemostatic Function During 21-Day Cold Storage: Insights from the Chilled Platelet Study in Vitro (CHIPSiv)
  • 5:00 PM - 6:00 PM  PT
    AM25-MN-36-L - Asian-type DEL Among D-Negative Patients and Donors in Malaysia Can Ease the Demand for D-Negative Red Cells and RhIG
  • 5:00 PM - 6:00 PM  PT
    AM25-MN-36-L - Growing a RH Variant Donor Database to Meet the Demands for RH Allele-Matched Requests
  • 5:00 PM - 6:00 PM  PT
    AM25-MN-36-L - Molecular Characterization of Variant D Antigen Expression Among 56,445 Blood Donors in East India
  • 5:00 PM - 6:00 PM  PT
    AM25-MN-36-L - Oral Abstract Session - Novel RHD Variants and Approaches to Overcoming Them
  • 5:00 PM - 6:00 PM  PT
    AM25-MN-36-L - Partial RHD Genotypes in Genetic-Ancestry Genome Databases
  • 6:15 PM - 7:30 PM  PT
    Research and Progress (RAPS): Organoids in Research and Biotherapies: Promise, Progress, and Challenges
  • 7:30 PM - 9:30 PM  PT
    President's Reception